Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2005

View Archived Issues

CDC recommends Menactra meningococcal vaccine for adolescents, college freshmen

Further monitoring required for Elidel, Protopic postmarketing adverse events

PRO-2000 studied in new NIAID-sponsored international trial

Xinlay NDA accepted for filing

NicOx selected to join EICOSANOX

Abbott and OraSure sign distribution agreement for OraQuick Advance test

Bavarian Nordic to raise capital for new programs

New phase II trial for Gabapentin ER in postherpetic neuralgia

Topline data from STRIDE-2 study in PAH

Sarissa inlicenses antisense drug from Isis

Tripep seeks approval for Thai HIV trial of alpha-HGA

Vanos receives FDA approval

Private financing at Voyager to fund Alzheimer's drug development

FDA COX-2 safety review to explore potential mechanisms of risk

New data on the effects of rosiglitazone on lipid metabolism in type 2 diabetes

Antitumor effects reported for Davanat plus 5-fluorouracil in patients with advanced solid tumors

Darbepoetin alfa improves chemotherapy-induced anemia in patients with gastrointestinal cancers

Antibacterial prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone claimed in Pfizer patent

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Genelabs Technologies presents novel antiviral agents

New 5-HT receptor modulators claimed by Suven Life Sciences

Merck Frosst claims novel inhibitors of leukotriene biosynthesis

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Tibolone reduces hot flushes and sweats in tamoxifen-treated breast cancer patients

AMN-107, a novel Bcr-Abl kinase inhibitor for the treatment of CML

Efficacy of the GABA-B receptor agonist CGP-44532 in response to nicotine

New evidence for the involvement of mGluR2/3 in primate cognitive function

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...